COVID-19 brings along an ever-growing concern for infected patients who have recovered from the acute phase of the viral infection. These individuals are now suffering from the long-term adverse health effects as a result. These long-term complications (aka long COVID-19), have been shown to affect everyone; including the chronically-sick, the healthy, and even the professional athlete.
“Long COVID-19 patients show systemic inflammation and persistent symptoms such as fatigue and malaise, profoundly affecting their quality of life”
Hyperbaric oxygen therapy (HBOT) has been shown to help the body produce a strong anti-inflammatory response that may be able to help combat Long Covid and provide symptomatic relief.
This study evaluated 5 subjects, (2 patients and 3 athletes) undergoing HBOT for 30 sessions and all 5 showed attenuation of inflammatory biomarkers, particularity the 2 athletes. “From this preliminary observation, HBOT could be considered a potential treatment for long COVID-19 patients.” <view study>